Literature DB >> 31393569

Pregnancy and Live Birth In Women With Pathogenic LHCGR Variants Using Their Own Oocytes.

Xuefeng Lu1, Zheng Yan1, Renfei Cai1, Shuzin Khor1, Ling Wu1, Lihua Sun2, Yun Wang1, Yao Xu3, Hui Tian2, Qiuju Chen1, Jie Qiao4, Bing Li1, Biaobang Chen3, Yu Cao5, Qifeng Lyu1, Lei Wang3, Yanping Kuang1.   

Abstract

CONTEXT: The LH/chorionic gonadotropin receptor (LHCGR) is mainly expressed in gonads and plays important roles in estradiol production, ovulation, and luteal formation. Women with pathogenic LHCGR variants suffer from infertility, and successful fertility treatments for such women have never been reported.
OBJECTIVE: The purpose of this study was to determine whether women with pathogenic LHCGR variants can achieve successful pregnancies through in vitro fertilization.
DESIGN: Three women with LH resistance and infertility and their parents underwent exome sequencing. The biochemical characteristics and functional effects of LHCGR mutation were assessed in transfected human embryonic kidney -293T cells and primary granulosa cells.
RESULTS: All affected women harbored pathogenic LHCGR variants. The LHCGR variants lacked cell surface localization and signal transduction abilities in vitro and in vivo. After dual triggering and prolonging the interval between triggering and oocyte pick-up, all three patients achieved oocytes and high-quality embryos. After frozen embryo transfer, one woman successfully birthed twins, and one woman successfully birthed a live boy. Apart from difficulties in oocyte retrieval, no obvious abnormalities in fertilization or during embryo development and pregnancy were identified in these patients.
CONCLUSIONS: This study is, to our knowledge, the first to report successful assisted reproductive treatment of women with pathogenic LHCGR variants using their own oocytes. Our results supported that defects in LHCGR disrupted ovulation but had no effect on fertilization and embryo development.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31393569     DOI: 10.1210/jc.2019-01276

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Novel mutations in LHCGR (luteinizing hormone/choriogonadotropin receptor): expanding the spectrum of mutations responsible for human empty follicle syndrome.

Authors:  Zhihua Zhang; Ling Wu; Feiyang Diao; Biaobang Chen; Jing Fu; Xiaoyan Mao; Zheng Yan; Bin Li; Jian Mu; Zhou Zhou; Wenjing Wang; Lin Zhao; Jie Dong; Yang Zeng; Jing Du; Yanping Kuang; Xiaoxi Sun; Lin He; Qing Sang; Lei Wang
Journal:  J Assist Reprod Genet       Date:  2020-08-28       Impact factor: 3.412

Review 2.  The Roles of Luteinizing Hormone, Follicle-Stimulating Hormone and Testosterone in Spermatogenesis and Folliculogenesis Revisited.

Authors:  Olayiwola O Oduwole; Ilpo T Huhtaniemi; Micheline Misrahi
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

3.  Case Report: A Novel Heterozygous ZP3 Deletion Associated With Empty Follicle Syndrome and Abnormal Follicular Development.

Authors:  Yongzhe Chen; Zesong Wang; Yueren Wu; Wenbin He; Juan Du; Sufen Cai; Fei Gong; Guangxiu Lu; Ge Lin; Can Dai
Journal:  Front Genet       Date:  2021-05-19       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.